EU Policymakers Under Industry Pressure To 'Neuter' SPC Waiver Plan

“Vested interests” are pressuring EU policymakers to water down further European Commission plans for an exemption intended to allow generic and biosimilar firms to manufacture their versions of products for export while SPCs are still in effect, claims the industry sector body Medicines for Europe.

Pressure
EU policymakers are coming under pressure over a proposed SPC waiver, says generics industry body

More from Biosimilars

More from Biosimilars & Generics